ALEXANDRIA, Va., June 16 -- United States Patent no. 12,303,477, issued on May 20, was assigned to NantCell Inc. (Culver City, Calif.) and NantKwest Inc. (Dan Diego, Calif.).
"HIV treatment compositions and methods" was invented by Kayvan Niazi (Culver City, Calif.), Jeffrey Safrit (Culver City, Calif.) and John H. Lee (Culver City, Calif.).
According to the abstract* released by the U.S. Patent & Trademark Office: "HIV treatment, and especially treatment of latent infected CD4 cells, can be significantly improved using a kick-and-kill approach that employs an immune stimulation component and/or HDAC inhibition as one treatment component, and that may also include a second component in which a vaccine composition, various NK cells, CAR-T ...